Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC). (Q38434338)
Jump to navigation
Jump to search
scientific article published on 23 January 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC). |
scientific article published on 23 January 2007 |
Statements
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC) (English)
Rosa Giuliani
Virginie Durbecq
Marianne Paesmans
Denis Larsimont
Jean-Yves Leroy
Marleen Borms
Anita Vindevoghel
Guy Jerusalem
Luc Dirix
Jean-Luc Canon
Vincent Richard
Veronique Cocquyt
Françoise Majois
Michel Reginster
Jan Demol
Jean-Pierre Kains
Paul Delree
Carine Keppens
Christos Sotiriou
Martine J Piccart
23 January 2007